|
Volumn 58, Issue 2, 2001, Pages 228-232
|
Assessment of the risk of positive surgical margins with 31 pelvic phased-array magnetic resonance imaging in patients with clinically localized prostate cancer: A prospective study
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PROSTATE SPECIFIC ANTIGEN;
ADULT;
AGED;
ARTICLE;
CANCER LOCALIZATION;
CANCER STAGING;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC IMAGING;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
MAJOR CLINICAL STUDY;
MALE;
MULTIVARIATE ANALYSIS;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PATHOLOGIST;
PREOPERATIVE CARE;
PRIORITY JOURNAL;
PROSTATE CARCINOMA;
PROSTATECTOMY;
PROTEIN BLOOD LEVEL;
RADIOLOGIST;
RANDOMIZED CONTROLLED TRIAL;
RISK ASSESSMENT;
RISK FACTOR;
TUMOR BIOPSY;
AGED;
BIOPSY;
HUMANS;
LYMPHATIC METASTASIS;
MAGNETIC RESONANCE IMAGING;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
ODDS RATIO;
PREDICTIVE VALUE OF TESTS;
PREOPERATIVE CARE;
PROSPECTIVE STUDIES;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATECTOMY;
PROSTATIC NEOPLASMS;
RISK ASSESSMENT;
SENSITIVITY AND SPECIFICITY;
|
EID: 0034908922
PISSN: 00904295
EISSN: None
Source Type: Journal
DOI: 10.1016/S0090-4295(01)01113-X Document Type: Article |
Times cited : (17)
|
References (25)
|